| Abstract: | Cyclic adenosine monophosphate (cAMP) modulates various agent‐induced apoptosis. In this study, we observed that cAMP had a significantly protective effect on nitric oxide (NO)‐induced cytotoxicity in H9c2 cardiac muscle cells. Pretreatment with DBcAMP (cAMP analogue) or forskolin (adenylyl cyclase activator) also significantly prevented the SNP‐induced apoptosis in H9c2 cells. In contrast, H‐89 or KT5720 (PKA inhibitor) reversed the protective effects of DBcAMP. In this study, DBcAMP or forskolin reduced SNP‐induced JNK/SAPK activation to the basal level, but KT5720 reversed the inhibitory effects of these two agents. In contrast to JNK/SAPK activation, DBcAMP and forskolin significantly enhanced SNP‐activated p38 MAPK phosphorylation and did not affect SNP‐mediated ERK activation. KT5720 reversed the effects of DBcAMP and forskolin on p38 MAPK phosphorylation. The inhibition of the JNK pathway by transfection of a dominant negative mutant of JNK/SAPK markedly reduced the extent of SNP‐induced cell death. Taken together, we suggest that JNK/SAPK is related to cAMP‐protective effect in SNP‐induced apoptosis. In addition, c‐AMP relating agents protected SNP‐induced cell death in neonatal rat ventricular cardiomyocytes. The cAMP‐relating agent‐induced protective effect is not resricted in H9c2 cardiac muscle cells. |
